Penumbra Revenue 2014-2019 | PEN

Penumbra annual/quarterly revenue history and growth rate from 2014 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Penumbra revenue for the quarter ending March 31, 2019 was $0.128B, a 25.06% increase year-over-year.
  • Penumbra revenue for the twelve months ending March 31, 2019 was $0.471B, a 29.57% increase year-over-year.
  • Penumbra annual revenue for 2018 was $0.445B, a 33.31% increase from 2017.
  • Penumbra annual revenue for 2017 was $0.334B, a 26.75% increase from 2016.
  • Penumbra annual revenue for 2016 was $0.263B, a 41.5% increase from 2015.
Penumbra Annual Revenue
(Millions of US $)
2018 $445
2017 $334
2016 $263
2015 $186
2014 $126
2013 $89
Penumbra Quarterly Revenue
(Millions of US $)
Q1 2019 $128
Q4 2018 $121
Q3 2018 $112
Q2 2018 $110
Q1 2018 $103
Q4 2017 $96
Q3 2017 $84
Q2 2017 $81
Q1 2017 $73
Q4 2016 $73
Q3 2016 $67
Q2 2016 $65
Q1 2016 $58
Q4 2015 $54
Q3 2015 $50
Q2 2015 $42
Q1 2015 $39
Q4 2014
Q3 2014 $32
Q4 2013
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.119B $0.445B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $115.923B 25.36
Intuitive Surgical (ISRG) United States $61.050B 53.31
Edwards Lifesciences (EW) United States $40.518B 40.49
IDEXX Laboratories (IDXX) United States $24.496B 64.26
Fresenius Medical Care AG KGaA (FMS) Germany $23.093B 15.17
Teleflex (TFX) United States $15.464B 33.51
Olympus (OCPNY) Japan $15.120B 113.13
SONOVA HOLDING (SONVY) Switzerland $14.591B 0.00
Sysmex ADR (SSMXY) Japan $14.533B 39.18
DexCom (DXCM) United States $13.892B 272.46
Hologic (HOLX) United States $12.939B 20.81
STERIS (STE) Ireland $12.366B 29.91
Varian Medical Systems (VAR) United States $12.078B 30.81
ABIOMED (ABMD) United States $11.795B 71.75
Masimo (MASI) United States $8.182B 50.13
SARTORIUS AG (SARTF) Germany $5.850B 51.98
Elekta AB (EKTAY) Sweden $5.087B 38.33
Integra LifeSciences Holdings (IART) United States $4.653B 21.86
Globus Medical (GMED) United States $4.220B 26.32
Tandem Diabetes Care (TNDM) United States $3.752B 0.00
LivaNova (LIVN) United Kingdom $3.543B 23.09
Wright Medical Group (WMGI) Netherlands $3.423B 678.50
Cantel Medical (CMD) United States $3.306B 33.54
Glaukos (GKOS) United States $2.735B 0.00
Integer Holdings (ITGR) United States $2.652B 19.54
Nihon Kohden (NHNKY) Japan $2.401B 24.16
AVANOS MEDICAL, INC (AVNS) United States $1.903B 30.11
Nevro (NVRO) United States $1.882B 0.00
Inogen (INGN) United States $1.287B 28.48
Silk Road Medical (SILK) United States $1.279B 0.00
OPKO Health (OPK) United States $1.274B 0.00
Veracyte (VCYT) United States $1.243B 0.00
CryoLife (CRY) United States $1.123B 111.37
Accelerate Diagnostics (AXDX) United States $1.017B 0.00
Tactile Systems Technology (TCMD) United States $1.009B 148.86
ORTHOFIX MEDICAL INC (OFIX) United States $0.963B 27.90
ViewRay (VRAY) United States $0.915B 0.00
Luminex (LMNX) United States $0.897B 117.35
Natus Medical (BABY) United States $0.893B 20.67
Mesa Laboratories (MLAB) United States $0.883B 41.29
Pacific Biosciences Of California (PACB) United States $0.814B 0.00
Fluidigm (FLDM) United States $0.793B 0.00
AngioDynamics (ANGO) United States $0.789B 25.84
AxoGen (AXGN) United States $0.756B 0.00
Quotient (QTNT) Switzerland $0.692B 0.00
Intersect ENT (XENT) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.511B 0.00
Si-Bone (SIBN) United States $0.485B 0.00
GenMark Diagnostics (GNMK) United States $0.351B 0.00
Accuray (ARAY) United States $0.350B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.350B 18.76
Semler Scientific (SMLR) United States $0.312B 61.99
RTI Surgical (RTIX) United States $0.303B 37.27
SeaSpine Holdings (SPNE) United States $0.241B 0.00
Neuronetics (STIM) United States $0.228B 0.00
Alphatec Holdings (ATEC) United States $0.210B 0.00
ConforMIS (CFMS) United States $0.209B 0.00
IRadimed (IRMD) United States $0.204B 38.89
Sientra (SIEN) United States $0.172B 0.00
Stereotaxis (STXS) United States $0.166B 0.00
Second Sight Medical Products (EYES) United States $0.112B 0.00
Ekso Bionics Holdings (EKSO) United States $0.090B 0.00
Sensus Healthcare (SRTS) United States $0.087B 0.00
Vermillion (VRML) United States $0.075B 0.00
EDAP TMS S.A (EDAP) France $0.075B 0.00
T2 Biosystems (TTOO) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
Apollo Endosurgery (APEN) United States $0.066B 0.00
Spectral Diagnostics (EDTXF) Canada $0.064B 0.00
Helius Medical Technologies (HSDT) United States $0.055B 0.00